Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silja Skogstad Tuv

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Forensic Science International|September 30, 2016
Blood concentrations of new designer benzodiazepines in forensic casesGudrun Høiseth, Silja Skogstad Tuv, Ritva Karinen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 29, 2020
Genotyping may result in fewer adverse effects in cancer therapySilja Skogstad Tuv, Tormod Karlsen Bjånes, Kristin Nordal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 8, 2019
Pharmacogenetics in personalised drug therapySilja Skogstad Tuv, Kristin Nordal, Nils Tore Vethe, et al.
Forensic Science International|December 9, 2014
Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoidsRitva Karinen, Silja Skogstad Tuv, Elisabeth Leere Øiestad, et al.
Traffic Injury Prevention|April 16, 2015
Methiopropamine in blood samples from drivers suspected of being under the influence of drugsSilja Skogstad Tuv, Marianne Skov-Skov Bergh, Vigdis Vindenes, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 27, 2023
[New tool for interpreting pharmacogenetic analyses]Silja Skogstad Tuv, Olav Spigset, Elena Jensen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 11, 2016
[Drug safety associated with the change of digitalis drug in Norway]Christian Haga, Mimi Stokke Opdal, Silja Skogstad Tuv, et al.
Accident; Analysis and Prevention|October 17, 2013
Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks periodSilja Skogstad Tuv, Hege Krabseth, Ritva Karinen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 6, 2013
[Effect and occurrence of synthetic cannabinoids]Silja Skogstad Tuv, Maren Cecilie Strand, Ritva Karinen, et al.
Forensic Science International|September 14, 2014
Lethal poisonings with AH-7921 in combination with other substancesRitva Karinen, Silja Skogstad Tuv, Sidsel Rogde, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Forensic Science International|September 30, 2016
Blood concentrations of new designer benzodiazepines in forensic casesGudrun Høiseth, Silja Skogstad Tuv, Ritva Karinen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 29, 2020
Genotyping may result in fewer adverse effects in cancer therapySilja Skogstad Tuv, Tormod Karlsen Bjånes, Kristin Nordal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 8, 2019
Pharmacogenetics in personalised drug therapySilja Skogstad Tuv, Kristin Nordal, Nils Tore Vethe, et al.
Forensic Science International|December 9, 2014
Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoidsRitva Karinen, Silja Skogstad Tuv, Elisabeth Leere Øiestad, et al.
Traffic Injury Prevention|April 16, 2015
Methiopropamine in blood samples from drivers suspected of being under the influence of drugsSilja Skogstad Tuv, Marianne Skov-Skov Bergh, Vigdis Vindenes, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 27, 2023
[New tool for interpreting pharmacogenetic analyses]Silja Skogstad Tuv, Olav Spigset, Elena Jensen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 11, 2016
[Drug safety associated with the change of digitalis drug in Norway]Christian Haga, Mimi Stokke Opdal, Silja Skogstad Tuv, et al.
Accident; Analysis and Prevention|October 17, 2013
Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks periodSilja Skogstad Tuv, Hege Krabseth, Ritva Karinen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 6, 2013
[Effect and occurrence of synthetic cannabinoids]Silja Skogstad Tuv, Maren Cecilie Strand, Ritva Karinen, et al.
Forensic Science International|September 14, 2014
Lethal poisonings with AH-7921 in combination with other substancesRitva Karinen, Silja Skogstad Tuv, Sidsel Rogde, et al.
Pageof 2